(Q34402967)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Laura Sutton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Munir Pirmohamed

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

A A Ghani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A Jorgensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

E Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M Murray

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Michael

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

I Peart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

R L Smyth

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

8 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

542-548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

A pharmacogenetic versus a clinical algorithm for warfarin dosing

8 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Aspects of anticoagulation in children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Role of warfarin pharmacogenetic testing in clinical practice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Estimation of the warfarin dose with clinical and pharmacogenetic data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Genetic determinants of response to warfarin during initial anticoagulation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Pharmacogenetics of warfarin: current status and future challenges

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

How I treat venous thrombosis in children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Anticoagulation with warfarin in infants and children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Oral anticoagulation in paediatric patients: dose requirements and complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

A method to determine the optimal intensity of oral anticoagulant therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209173

Acenocoumarol therapy in pediatric patients

6 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

Pharmacogenomics of warfarin dose requirements in Hispanics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

A randomized trial of genotype-guided dosing of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

Pediatric warfarin practice and pharmacogenetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

Developmental expression of human hepatic CYP2C9 and CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

Equal proportion of adult male and female homozygous for the 677C ? T mutation in the methylenetetrahydrofolate reductase polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.31

Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients

21 January 2018

1 reference

12 December 2020

Antithrombotic therapy in children

1 reference

12 December 2020

Oral anticoagulation therapy in pediatric patients: a prospective study

1 reference

12 December 2020

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

12 December 2020

The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children

1 reference

12 December 2020

Identifiers

DOI

10.1038/TPJ.2014.31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 March 2020

1034665251

0 references

Fatcat ID

release_3usflooeund5vpumh7omgsqyea

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3usflooeund5vpumh7omgsqyea

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

PubMed publication ID

25001883

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25001883%20AND%20SRC:MED&resulttype=core&format=json